HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiyasu Taniguchi Selected Research

Complementation Group D1 Fanconi Anemia

11/2007The Fanconi anemia pathway and ubiquitin.
6/2006Molecular pathogenesis of Fanconi anemia: recent progress.
1/2005Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.
5/2003Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiyasu Taniguchi Research Topics

Disease

23Neoplasms (Cancer)
01/2019 - 02/2002
19Fanconi Anemia (Fanconi's Anemia)
01/2019 - 02/2002
7Breast Neoplasms (Breast Cancer)
01/2019 - 04/2006
6Carcinoma (Carcinomatosis)
03/2013 - 02/2008
5Ovarian Neoplasms (Ovarian Cancer)
12/2013 - 06/2006
5Hypersensitivity (Allergy)
11/2007 - 02/2002
4Chromosome Breakage
02/2017 - 02/2002
4Aplastic Anemia (Anemia, Hypoplastic)
11/2007 - 02/2002
4Complementation Group D1 Fanconi Anemia
11/2007 - 05/2003
2Carcinogenesis
01/2016 - 01/2006
2Genomic Instability
12/2013 - 08/2011
2Chromosome Aberrations (Chromosome Abnormalities)
03/2013 - 01/2005
2Chromosomal Instability (Chromosome Stability)
08/2011 - 08/2004
2Inborn Genetic Diseases (Disease, Hereditary)
11/2007 - 06/2006
2Leukemia
11/2007 - 06/2006
1Osteosarcoma (Osteogenic Sarcoma)
12/2013
1Ovarian Epithelial Carcinoma
08/2010
1Ascites
08/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2008
1Glioma (Gliomas)
05/2007
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
06/2006
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2006
1Second Primary Neoplasms (Neoplasms, Second)
01/2006
1Bone Marrow Failure Disorders
02/2003
1Ataxia Telangiectasia (Louis Bar Syndrome)
12/2002

Drug/Important Bio-Agent (IBA)

17DNA (Deoxyribonucleic Acid)IBA
01/2019 - 02/2002
12Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2002
12Cisplatin (Platino)FDA LinkGeneric
01/2019 - 05/2003
7Mitomycin (Mitomycin-C)FDA LinkGeneric
06/2006 - 07/2002
6PlatinumIBA
01/2016 - 04/2008
5Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2016 - 08/2010
4BRCA1 ProteinIBA
01/2016 - 04/2008
4A-Form DNA (A-DNA)IBA
04/2012 - 04/2006
3Platinum Compounds (Compounds, Platinum)IBA
04/2012 - 02/2008
2MicroRNAs (MicroRNA)IBA
06/2014 - 12/2013
2Carboplatin (JM8)FDA LinkGeneric
04/2012 - 04/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
04/2012 - 08/2007
2Proteasome InhibitorsIBA
04/2012 - 08/2007
2BRCA2 ProteinIBA
08/2009 - 07/2009
2UbiquitinIBA
11/2007 - 06/2006
2Melphalan (Alkeran)FDA LinkGeneric
08/2007 - 06/2006
2CurcuminIBA
05/2007 - 04/2006
2Small Interfering RNA (siRNA)IBA
03/2005 - 08/2004
1Hydroxyurea (Hydrea)FDA LinkGeneric
02/2017
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2016
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2016
1Messenger RNA (mRNA)IBA
03/2013
1Tumor Suppressor p53-Binding Protein 1IBA
03/2013
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2013
1Pharmaceutical PreparationsIBA
04/2012
1Bortezomib (Velcade)FDA Link
04/2012
1Cathepsin BIBA
04/2012
1tanespimycin (17AAG)IBA
04/2012
1Histones (Histone)IBA
08/2011
1MutL Protein Homolog 1IBA
07/2009
1Urea (Carbamide)FDA LinkGeneric
05/2007
1Alkylating AgentsIBA
05/2007
1Carmustine (FIVB)FDA Link
05/2007
1Temozolomide (Temodar)FDA LinkGeneric
05/2007
1Ligases (Synthetase)IBA
06/2006
1Fanconi Anemia Complementation Group D2 ProteinIBA
04/2006
1Biomarkers (Surrogate Marker)IBA
01/2006
1ChromatinIBA
02/2005
1Phosphotransferases (Kinase)IBA
12/2002
1Fanconi Anemia Complementation Group C ProteinIBA
10/2002
1Complementary DNA (cDNA)IBA
10/2002

Therapy/Procedure

10Drug Therapy (Chemotherapy)
02/2017 - 01/2006
5Therapeutics
01/2019 - 07/2009
2Radiotherapy
08/2011 - 01/2006
1Neoadjuvant Therapy
07/2009
1Aftercare (After-Treatment)
01/2005